Applicants should possess at least a UK lower second class honours degree (2:2) or equivalent in bioscience, biochemistry, chemistry, pharmacy medicine or related subject.
This course is aimed at students who wish to acquire the specialised skills needed to design drugs for the 21st century. It is ideal for anyone with primarily either a chemistry or biochemistry based undergraduate degree wishing to broaden their knowledge base. The part-time route is well suited to those who already work in industry as it is possible to carry out research projects within the place of work. Prospective students must be committed to developing their skills and knowledge for a career in the pharmaceutical or biotechnology sectors.
Accreditation of Prior Learning (APL)
We welcome applications from students who may not have formal/traditional entry criteria but who have relevant experience or the ability to pursue the course successfully.
The Accreditation of Prior Learning (APL) process could help you to make your work and life experience count. The APL process can be used for entry onto courses or to give you exemptions from parts of your course.
Two forms of APL may be used for entry: the Accreditation of Prior Certificated Learning (APCL) or the Accreditation of Prior Experiential Learning (APEL).
Months of entry
It is an exciting time for chemists to be involved in all aspects of biomedical research. Chemistry is inherently well positioned to have a major impact on drug discovery, since other disciplines cannot create novel small molecules. This course offers classical natural products-based drug discovery, involving extraction, assay-based functional fractionation, isolation, characterization, and target validation however increasingly this approach is complemented by molecular target-based drug discovery and Molecular Modelling. Discovery of new generation antimicrobials against multidrug resistant strains of bacteria is advancing by extensive use of those modern tools. Furthermore Nanotechnology is fulfilling medical science’s need for more precise treatments that are less invasive, less costly, and less complicated to administer than traditional methods that translate into better patient outcomes, lower healthcare costs, and wider access to healthcare services in under-resourced parts of the world.
Finally following completion of the Human Genome Project, the pharmaceutical industry is also preparing for a revolution in cancer and inherited disorder therapies. This course is training a new generation of bioscientists to meet challenges at the interface between biology and chemistry, and to apply pharmaceutical and analytical knowledge directly to improve quality of life.
The syllabus is designed to develop the “analytical techniques and problem-solving skills” relevant to postgraduate-level employment in both the pharmaceutical sector but also to provide access to transferable skills relevant to a great variety of professional careers.
- Learn to meet challenges at the interface between biology and chemistry and to apply pharmaceutical and analytical knowledge directly to improve quality of life.
- Learn where chemistry, nanotechnology and genome technology is pushing the boundaries of biomedical research.
- Develop the tools to enhance your employability including analytical techniques and problem-solving skills.
- Acquire strong training in drug synthesis and analytical methods, natural product chemistry and molecular modelling
Information for international students
International applicants will be required to show a proficiency in English. An IELTS score of 6.0 (no element below 5.5) is proof of this.
Fees and funding
Qualification and course duration
Course contact details
- Course Enquiries
- +44 (0) 161 295 4545